Physician profile
Joanna Esterow
NPI 1194910083
$5,499.22
in general payments reported to CMS, 2019-2025
16 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,545 · 2022: $1,436 · 2023: $2,298 · 2024: $14.50 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,723 · Consulting Fee: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,722.83 |
| Consulting Fee | $795.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $1,366.45 | 2021-2025 | Entyvio, Gattex |
| Abbvie INC. | $1,321.94 | 2021-2023 | |
| Janssen Biotech, INC. | $666.60 | 2021-2025 | Stelara, Tremfya |
| Lilly USA, LLC | $665.64 | 2021-2025 | Omvoh |
| Celgene Corporation | $439.03 | 2021-2023 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $262.60 | 2021-2023 | Xifaxan |
| Novo Nordisk INC | $249.99 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $129.85 | 2022-2023 | Rebyota, Clenpiq |
| Celltrion USA INC. | $125.00 | 2025 | Zymfentra |
| Organon LLC | $103.32 | 2022-2023 | Hadlima, Renflexis |
| Nestle Healthcare Nutrition INC. | $70.36 | 2021-2022 | |
| Daiichi Sankyo INC. | $26.52 | 2022 | |
| Alcresta Therapeutics, INC. | $24.11 | 2023 | Relizorb |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.12 | 2023 | Cyltezo |
| Dynavax Technologies Corporation | $15.43 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanna Esterow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.